Who We Are
Call Us: 1-800-738-6337
1800PetMeds® Press Releases
Call Us: 1-800-738-6337
PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS SECOND QUARTER FINANCIAL RESULTS
Pompano Beach, Florida, October 21, 2013 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended September 30, 2013. Net sales for the quarter ended September 30, 2013 were $60.5 million, compared to $58.1 million for the quarter ended September 30, 2012, an increase of 4.0%. Net sales for the six months ended September 30, 2013 were $134.7 million, compared to $127.1 million for the quarter ended September 30, 2012, an increase of 6.0%. Net income was $4.2 million, or $0.21 diluted per share, for the quarter ended September 30, 2013, compared to net income of $4.0 million, or $0.20 diluted per share, for the quarter ended September 30, 2012, a 3.0% increase to EPS. Net income was $8.9 million, or $0.44 diluted per share, for the six months ended September 30, 2013, compared to net income of $8.0 million, or $0.40 diluted per share, for the six months ended September 30, 2012, a 12.2% increase to EPS. Reorder sales increased by 5.3%, from $46.4 million to $48.9 million for the quarters ended September 30, 2012 and 2013, respectively. Additionally, the Companyâ€™s online sales increased by 7.3% to $47.9 million for the quarter ended September 30, 2013, compared to $44.6 million for the same quarter the prior year, with approximately 79% of all orders being generated from its website during the quarter compared to 77% for the same quarter the prior year.
Menderes Akdag, CEO and President, commented: â€œWe are pleased with the strong reorder sales for the quarter. Our sales increase for the quarter was also highlighted by an increased average order size - $73 for the quarter ended September 30, 2013 compared to $72 for the same quarter in the prior year. For the quarter ended September 30, 2013 our operating expenses decreased by 140 basis points, mainly due to a reduction in advertising expenses. Cash flow from operations increased by 55%, from $15.7 million to $24.4 million for the quarters ended September 30, 2012 and 2013, respectively. For the remainder of Fiscal 2014 we are focusing on improving our gross profit margins and continuing to expand our product offerings.â€
This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarterâ€™s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on October 21, 2013 until November 4, 2013 at 11:59 P.M. To access the replay, call (800) 454-0163 (toll free) or (203) 369-3803, and enter passcode 5500.
Founded in 1996, PetMed Express is Americaâ€™s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.
This press release may contain â€œforward-lookingâ€ statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Companyâ€™s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such â€œforward-lookingâ€ statements are set forth in Managementâ€™s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2013. The Companyâ€™s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.